|
TNFAIP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.572200E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.362590E-04 |
| Normal-vs-Stage2 |
1.263880E-02 |
| Normal-vs-Stage3 |
2.293500E-02 |
| Normal-vs-Stage4 |
5.377600E-02 |
| Stage1-vs-Stage2 |
5.649000E-01 |
| Stage1-vs-Stage3 |
3.352600E-01 |
| Stage1-vs-Stage4 |
1.945970E-01 |
| Stage2-vs-Stage3 |
7.893000E-01 |
| Stage2-vs-Stage4 |
5.689400E-01 |
| Stage3-vs-Stage4 |
7.546000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.09880000000751E-05 |
| Normal-vs-AfricanAmerican |
8.023600E-02 |
| Normal-vs-Asian |
4.016300E-02 |
| Caucasian-vs-AfricanAmerican |
7.133600E-01 |
| Caucasian-vs-Asian |
5.345800E-01 |
| AfricanAmerican-vs-Asian |
9.316400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.777800E-03 |
| Normal-vs-Female |
2.976600E-04 |
| Male-vs-Female |
7.670400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.7410199999901E-05 |
| Normal-vs-Age(41-60Yrs) |
1.306090E-02 |
| Normal-vs-Age(61-80Yrs) |
8.756300E-02 |
| Normal-vs-Age(81-100Yrs) |
1.096000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.539840E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.859300E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.740400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.122200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.576400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.570550E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.625200E-01 |
| Classical-VS-Follicular |
1.31489996668677E-09 |
| Classical-VS-Other |
1.173170E-01 |
| Classical-VS-Normal |
1.16090000001901E-06 |
| Tall-VS-Follicular |
8.375800E-03 |
| Tall-VS-Other |
2.046600E-01 |
| Tall-VS-Normal |
1.585670E-02 |
| Follicular-VS-Other |
9.413200E-01 |
| Follicular-VS-Normal |
7.943000E-01 |
| Other-VS-Normal |
9.664000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.010400E-02 |
| Normal-vs-N1 |
6.225700E-02 |
| N0-vs-N1 |
5.711000E-01 |
|
|
